Plasma and liver lipid species as biomarkers of fatty liver

Johan Auwerx, Pooja Jha
2018
Brevet

Résumé

The invention relates to plasma or liver lipid species selected from the triacylglycerol (TAG) and cardiolipin (CL) lipid classes measured by LC-MS/MS and use thereof as diagnostic and prognostic biomarkers of fatty liver, as well as to monitor the efficacy of preventive and therapeutic measures to lower liver fat content.

Source officielle

https://infoscience.epfl.ch/record/273066?ln=fr

À propos de ce résultat

Cette page est générée automatiquement et peut contenir des informations qui ne sont pas correctes, complètes, à jour ou pertinentes par rapport à votre recherche. Il en va de même pour toutes les autres pages de ce site. Veillez à vérifier les informations auprès des sources officielles de l'EPFL.

Plasma and liver lipid species as biomarkers of fatty liver

Anti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1

Characterization of Cyclo His-Pro for the prevention and treatment of liver disease and muscular dystrophy

Characterization of Cyclo His-Pro for the prevention and treatment of liver disease and muscular dystrophy

Anti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1